Low-Molecular-Weight Heparins

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

• Revision history
  • April 2022; March 2020; March 2018; May 2017; April 2015; Feb. 2015; May 2013; June 2011; Jan. 2009; Aug. 2003; July 2002; July 2001; Aug. 2000. 
• Initially developed
  • Aug. 1999